Based on these results, patients were divided into three different prognostic groups: (A) good prognosis primary tumor and physiological C-reactive protein with 1-year survival rate of 89 %; (B) poor prognosis primary tumor and physiological C-reactive protein or good prognosis primary tumor and pathological C-reactive protein with 1-year survival rate of 57 %; (C) poor prognosis primary tumor and pathological C-reactive protein with 1-year survival rate of 13 % [58]. Here, CRP is linked to neoplasm.